-
Leaders Assemble for the IASLC 2025 World Conference on Lung Cancer: A Focus on Global Collaboration and Innovation
Four international experts will jointly chair the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer (WCLC), scheduled to take place in Barcelona from September 6 to 9, 2025. Here is an introduction to the incoming co-chairs who will guide the planning of WCLC 2025 and serve as ambassadors…
-
ESMO 2024丨Dr. Dingwei Ye’s Team Showcases Chinese Expertise and Innovation in Urologic Oncology on the International Stage
The 2024 European Society for Medical Oncology (ESMO) Congress took place from September 13 to 17 in Barcelona, Spain. As an annual highlight in the oncology field, ESMO attracts thousands of leading oncologists from around the world, providing a rich platform for global academic exchange. This year, multiple studies from Dr. Dingwei Ye’s team at…
-
SGBCC China Tour丨Dr. Yongmei Yin: Promoting Exchange, Building Consensus, Showcasing the International Power of Chinese Female Experts
On October 19-20, 2024, the first stop of the “St. Gallen Breast Cancer Conference (SGBCC) China Tour” was held in Nanjing. This series of events, organized by the Breast Cancer Expert Committee of the Chinese Society of Clinical Oncology (CSCO), the Beijing CSCO Clinical Oncology Research Foundation, the Beijing Kexin Medical Development Foundation, and the…
-
SIBCS 2024丨Dr. Lei Fan: Advances and Controversies in Adjuvant Therapy for Breast Cancer
Breast cancer is one of the most common malignancies among women globally, and continuous advancements in treatment modalities have brought new hope to many patients. At the 2024 SIBCS conference during the “Fourth 3C Summit Forum – Frontline Notes on the 2025 Breast Cancer Guideline Revision,” Dr. Lei Fan from Fudan University Shanghai Cancer Center…
-
Dr. Kaixiong Tao: Winning in Integrated Oncology Treatment, Striving to Be the “Internist with a Scalpel” | 2024 CACA
The 2024 CACA Integrative Gastric Cancer Conference was held in Wuhan from October 18-19, bringing together domestic and international experts across multiple disciplines in gastric cancer. Oncology Frontier had the privilege to interview Dr. Kaixiong Tao, Executive Chair of this year’s conference and Professor from Wuhan Union Hospital of China. Prof. Tao discussed the core…
-
HAIC Revolutionizes Postoperative Adjuvant Therapy for Liver Cancer, Focusing on Patient Survival and Quality of Life | IHBC 9th Academic Symposium
From October 24-27, 2024, the 9th Academic Symposium of the International Hepato-Pancreato-Biliary Association (IHPBA) China Chapter took place in Wuhan. In the field of liver cancer adjuvant therapy, Dr. Minshan Chen from the Sun Yat-sen University Cancer Center presented new treatment strategies. Oncology Frontier invited Prof. Chen for an in-depth interview, where he shared insights…
-
ILCA 2024 | Dr. Guohong Han: Exploring Advances and Prospects in Liver Cancer Treatment
Liver cancer is a major global health threat, and ongoing exploration into treatment strategies remains a focal point in medical research. From October 17 to 19, 2024, top experts and scholars in the field of liver cancer gathered in Toronto, Canada, for the 18th International Liver Cancer Association (ILCA) Annual Meeting. This conference brought together…
-
Dr. Feng Shen: Establishing a New Front in Liver Cancer Prevention and Treatment with the Liver Tumor Committee
From October 24 to 27, 2024, the 9th Academic Symposium of the Chinese Division of the International Hepato-Pancreato-Biliary Association (IHPBA) was held in Wuhan. Experts discussed pressing issues and innovations in hepatobiliary and pancreatic surgery, exchanging diagnostic and treatment experiences, promoting new ideas and techniques, and advancing the management of hepatobiliary diseases in China. During…
Connecting Medical Expertise through Media